Temsirolimus: a safety and efficacy review.

Temsirolimus: a safety and efficacy review.

Item
http://www.wikidata.org/entity/Q38031941
Temsirolimus inhibits proliferation and migration in retinal pigment epithelial and endothelial cells via mTOR inhibition and decreases VEGF and PDGF expressionMammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma.Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma.FK506-binding protein 12 ligands: a patent review.Adverse events associated with mTOR inhibitors.Mapping genetic alterations causing chemoresistance in cancer: identifying the roads by tracking the drivers.Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial.mTOR inhibitors in urinary bladder cancer.Therapy of mRCC beyond mTOR-inhibition in clinical practice: results of a retrospective analysis.Activation of the MAPK/ERK Cell-Signaling Pathway in Uterine Smooth Muscle Cells of Women With Adenomyosis.
P2860

Temsirolimus: a safety and efficacy review.

Item
http://www.wikidata.org/entity/Q38031941
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Temsirolimus: a safety and efficacy review.
@en
type
label
Temsirolimus: a safety and efficacy review.
@en
prefLabel
Temsirolimus: a safety and efficacy review.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Temsirolimus: a safety and efficacy review.
@en
P2093
P2860
P304
P31
P356
10.1517/14740338.2012.713344
P407
P433
P478
P577
P698